Academic drug discovery in an age of research abundance, and the curious case of chemical screens toward drug repositioning

药物发现 范围(计算机科学) 相关性(法律) 计算机科学 数据科学 药品 药物开发 制药工业 计算生物学 医学 生物信息学 生物 药理学 政治学 法学 程序设计语言
作者
Alessandro Datti
出处
期刊:Drug Discovery Today [Elsevier BV]
卷期号:28 (5): 103522-103522 被引量:2
标识
DOI:10.1016/j.drudis.2023.103522
摘要

High-throughput screening (HTS) is a vaunted technology in drug discovery, and drug repositioning a celebrated strategy with famous examples of successful stories; however, repositioned drugs have primarily resulted from serendipitous observations, retrospective studies, and pharmacological analyses as opposed to experimental routes. This observation points to a methodological paradox, considering that academic laboratories of the post-genomic era have benefited from unprecedented technological progress, and a facilitated access to powerful resources that, historically, were a prerogative of the pharma industry. This disconnect is exacerbated by financial, practical, and regulatory complexities affecting drug repositioning; however, the pivotal significance of stringent and rigorous data is what unconditionally sits at the crossroad of go/no-go decisions concerning the therapeutic significance, or predictive validity, of selected drugs. Here, I propose a visionary approach, to which I assigned the term labsourcing, to dramatically enhance efficiency and clinical relevance of academic drug screens and, ultimately, generate contextual and reproducible data for correct interpretations and reliable selection of drug candidates. The overall concept implies intra- and intermural aggregation of expertise (e.g., assay development, cell biology, statistics, bioinformatics) to perform multiple bioassays, under multiple conditions and readouts, using a common screening collection. Advantages of high input screens can be manifold: (i) to tackle discrepancies that may arise from the screens of libraries of variable size and content and assay types and conditions too narrow in scope; (ii) the opportunity to generate massive amounts of data applicable for multiple publications and funding requests; (iii) the educational benefits for students and post-docs collegially exposed to long-term programs; and (iv) the opportunity to democratize research and recruit small labs that could not otherwise join screening programs due to costs, timelines, and risks.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
地动完成签到 ,获得积分10
6秒前
于生有你完成签到,获得积分10
9秒前
Ava的应助被科研通管家采纳,获得10
10秒前
老迟到的断秋完成签到,获得积分10
10秒前
YifanWang的应助被科研通管家采纳,获得10
10秒前
彩色的冥茗完成签到,获得积分10
13秒前
14秒前
wang完成签到,获得积分10
16秒前
zxcvbnmgx完成签到 ,获得积分10
17秒前
yulian完成签到,获得积分10
18秒前
冷傲新柔发布了新的文献求助10
20秒前
科研通AI6.4的应助被cfw采纳,获得10
22秒前
kyt_vip完成签到,获得积分10
23秒前
sun完成签到 ,获得积分10
24秒前
wangji_2017完成签到,获得积分10
24秒前
大模型的应助被黑熊精采纳,获得10
25秒前
虚心的紫夏完成签到,获得积分10
25秒前
qwe完成签到,获得积分10
26秒前
英姑的应助被豆豆采纳,获得10
26秒前
34秒前
qiancib202完成签到,获得积分0
34秒前
34秒前
ice发布了新的文献求助10
37秒前
迅速的念芹完成签到 ,获得积分10
38秒前
40秒前
Dogged完成签到 ,获得积分10
42秒前
cfw完成签到,获得积分10
42秒前
大意的火龙果完成签到 ,获得积分10
42秒前
Harold完成签到,获得积分10
46秒前
cfw发布了新的文献求助10
46秒前
幸运小张完成签到,获得积分0
47秒前
乐观寻芹完成签到,获得积分10
51秒前
从容的水壶完成签到 ,获得积分10
52秒前
彩色人生完成签到 ,获得积分10
54秒前
55秒前
daikai完成签到 ,获得积分10
55秒前
宗剑完成签到,获得积分10
58秒前
心无杂念完成签到 ,获得积分10
59秒前
LJ_2完成签到 ,获得积分0
1分钟前
高贵觅山完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180053
求助须知:如何正确求助?哪些是违规求助? 9570224
关于积分的说明 21808682
捐赠科研通 7776054
什么是DOI,文献DOI怎么找? 3433261
关于科研通互助平台的介绍 2557425
邀请新用户注册赠送积分活动 2479012